Viewing Study NCT01241695


Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2025-12-27 @ 9:15 PM
Study NCT ID: NCT01241695
Status: COMPLETED
Last Update Posted: 2012-07-02
First Post: 2010-11-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients
Sponsor: Fresenius Kabi
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2010-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to determine the safety, acceptability and the efficacy of a 12-week intervention with a diabetes-specific oral nutritional supplement on glycaemic control in type 2 diabetic patients with or at risk of malnutrition
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: